ArticleScientific reports2021

Target modulation and pharmacokinetics/pharmacodynamics translation of the BTK inhibitor poseltinib for model-informed phase II dose selection.

Joo-Yun Byun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.